The burden of psychotropic drug prescribingin people with dementia: a populationdatabase study

Age and Ageing
Bruce GuthrieColin McCowan

Abstract

to compare psychotropic prescribing in older people with dementia and the general elderly population. retrospective population database study in 315 General Practices. there were 271,365 patients aged > or = 65, of which 10,058 (3.7%) recorded as having dementia. epidemiology of psychotropic prescribing in older people with and without dementia; multilevel modelling of patient and practice characteristics associated with antipsychotic prescribing. people with dementia were currently prescribed an antipsychotic drug (17.7%), an antidepressant (28.7%) and a hypnotic/anxiolytic (16.7%). Compared to the general elderly population, antipsychotic prescribing was 17.4 [95% confidence interval (CI) 16.4-18.4], antidepressant prescribing 2.7 (95% CI 2.6-1.8) and hypnotic/anxiolytics 2.2 (95% 2.1-2.3) times more likely in people with dementia. Most antipsychotic prescribing in people with dementia was prolonged (> 16 weeks). Patients living in more deprived areas and registered with larger and more remote practices were more likely to be prescribed prolonged antipsychotics. over one in six patients are currently prescribed antipsychotic drugs known to be of little benefit and causing significant harm, with other psychotropics equally com...Continue Reading

References

Jun 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·J R CopelandC McWilliam
Aug 24, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S L GrayE B Larson
Jun 6, 2003·International Journal of Geriatric Psychiatry·James LindesayCarol Jagger
Jun 16, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C BerrK Ritchie
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Feb 28, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sebastian SchneeweissPhilip S Wang
Jun 6, 2007·Annals of Internal Medicine·Sudeep S GillPaula A Rochon
May 28, 2008·Archives of Internal Medicine·Paula A RochonJerry H Gurwitz
Aug 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Elmira ValiyevaGeoffrey M Anderson
Jun 3, 2009·Nature Reviews. Neurology·Clive G BallardConstantine G Lyketsos

❮ Previous
Next ❯

Citations

Feb 8, 2011·European Journal of Clinical Pharmacology·Maria RikalaSirpa Hartikainen
Mar 19, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jana SchulzeFalk Hoffmann
Mar 8, 2013·International Journal of Nursing Studies·Hanneke C BeerensJan P H Hamers
Feb 22, 2013·International Psychogeriatrics·Kirsten MooreBriony Dow
Sep 21, 2013·Journal of Clinical Psychopharmacology·Niklas Schmedt, Edeltraut Garbe
Apr 24, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Amanda ConnollyNitin Purandare
Dec 21, 2013·Research in Social & Administrative Pharmacy : RSAP·Linda Simoni-WastilaJudith A Lucas
Apr 22, 2015·International Journal of Geriatric Psychiatry·Lloyd D HughesBruce Guthrie
Apr 30, 2013·Aging & Mental Health·Hanne Mette O RidderChristian Gold
Aug 2, 2011·Pharmacoepidemiology and Drug Safety·Ellen Melbye LangballeHedvig Nordeng
Jun 30, 2011·International Journal of Geriatric Psychiatry·Ian D MaidmentCornelius Katona
May 5, 2012·The International Journal of Pharmacy Practice·Benjamin J BasgerRebekah J Moles
Mar 18, 2011·International Journal of Geriatric Psychiatry·Lucio GhioElda Rasore
Jul 22, 2014·Journal of the American Geriatrics Society·Yu-Jung WeiJudith A Lucas
Aug 4, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Marjaana KoponenSirpa Hartikainen
Dec 3, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Heidi TaipaleSirpa Hartikainen
Feb 7, 2015·BMC Geriatrics·Michael J AnnearAndrew Robinson
May 27, 2015·International Clinical Psychopharmacology·Heidi TaipaleSirpa Hartikainen
Jul 12, 2013·The International Journal of Neuropsychopharmacology·Ramit Ravona-Springer, Michael Davidson
May 31, 2016·International Journal of Geriatric Psychiatry·Alice BreiningArmelle Leperre-Desplanques
Apr 27, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Chris F JohnsonGazala Akram
Mar 6, 2018·Age and Ageing·Elizabeta B Mukaetova-Ladinska
Nov 28, 2017·Drugs & Aging·Mairead McGrattanCarmel M Hughes
Feb 15, 2014·British Journal of Nursing : BJN·Lloyd D HughesJohn Cordina
Feb 21, 2019·International Journal of Palliative Nursing·Anna SwallCarina Lundh Hagelin
Mar 13, 2019·British Journal of Hospital Medicine·Lloyd D HughesDavid J Findlay
Nov 21, 2013·International Psychogeriatrics·Bart C KleijerEibert R Heerdink
Jan 10, 2018·Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society·Michael J Annear
Aug 11, 2017·Journal of Clinical Psychopharmacology·Arduino A MangoniRichard J Woodman
Jun 25, 2020·Aging & Mental Health·Paul CampbellKelvin P Jordan
Aug 1, 2020·PloS One·Sirasa RuangritchankulLeonard C Gray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.